Skip to main navigation Skip to search Skip to main content

Adenoid cystic carcinoma of the lung: Response to tamoxifen after chemoradiation

  • Jia Liu*
  • , Eric Hau
  • , Matthew Links
  • , Peter H. Graham
  • *Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Primary adenoid cystic carcinoma of the lung is a rare subtype of lung cancer with a prolonged natural history but is difficult to completely resect surgically due to its proximal location. Hence radiotherapy plays a role for local control of these cancers. The role of systemic therapies in the treatment of adenoid cystic carcinoma of the lung remains unclear. Isolated case reports have previously described the treatment of primary adenoid cystic carcinoma of the lung with tamoxifen, resulting in partial control. We report the first case of primary adenoid cystic carcinoma of the lung treated with primary chemoradiotherapy due to unresectable location of the tumor, and disease stabilization with symptomatic response to tamoxifen following tumor recurrence. There is a need for further studies to investigate the role of anti-hormonal therapies in the treatment of adenoid cystic carcinoma of the lung.

Original languageEnglish
Pages (from-to)e352-e355
JournalAsia-Pacific Journal of Clinical Oncology
Volume12
Issue number2
DOIs
Publication statusPublished - 1 Jun 2016
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Adenoid cystic carcinoma of the lung: Response to tamoxifen after chemoradiation'. Together they form a unique fingerprint.

Cite this